Urinary system neoplasm
MONDO:0021066A benign or malignant, primary or metastatic neoplasm involving the urinary system. --2003
Also known as: neoplasm of renal system, neoplasm of the urinary system, neoplasm of the urinary tract, neoplasm of urinary system, neoplasm of urinary tract, renal system neoplasm, renal system neoplasm (disease), renal system tumor
3002 clinical trials for this condition and its sub-types, 21 tagged with Urinary system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urinary system neoplasm
-
Malignant urinary system neoplasm 75 trials · 1,668 incl. sub-types
10 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Urothelial carcinoma 364 trials · 695 incl. sub-types Sub-types →
- Urinary bladder cancer 40 trials · 686 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 187 incl. sub-types Sub-types →
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 2B 2 trials
- Malignant prostate phyllodes tumor 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Kidney neoplasm 59 trials · 860 incl. sub-types
8 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Childhood kidney neoplasm 1 trial · 30 incl. sub-types Sub-types →
- Renal pelvis neoplasm 1 trial · 24 incl. sub-types Sub-types →
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Mesonephric neoplasm 1 trial · 3 incl. sub-types Sub-types →
- Kidney hemangiopericytoma 0 trials
- Mixed epithelial stromal tumor of the kidney 0 trials Sub-types →
- Multiloculated renal cyst 0 trials
-
Urinary bladder neoplasm 65 trials · 703 incl. sub-types
6 sub-types
- Urinary bladder cancer 40 trials · 686 incl. sub-types Sub-types →
- Bladder flat intraepithelial lesion 0 trials · 30 incl. sub-types Sub-types →
- Bladder papillary urothelial neoplasm 1 trial · 13 incl. sub-types Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Bladder inflammatory myofibroblastic tumor 0 trials
- Urinary bladder villous adenoma 0 trials
-
Urothelial neoplasm 2 trials · 696 incl. sub-types
5 sub-types
- Urothelial carcinoma 364 trials · 695 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 187 incl. sub-types Sub-types →
- Papillary urothelial neoplasm 0 trials · 13 incl. sub-types Sub-types →
- Urinary tract non-invasive transitional cell neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Urothelial dysplasia 0 trials
-
Benign urinary system neoplasm 50 trials · 62 incl. sub-types
6 sub-types
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Benign prostate phyllodes tumor 0 trials
- Benign urethral neoplasm 0 trials Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Urothelial papilloma 0 trials Sub-types →
-
Ureter neoplasm 2 trials · 34 incl. sub-types
3 sub-types
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Polyp of ureter 0 trials
-
Urethra neoplasm 3 trials · 31 incl. sub-types
3 sub-types
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Benign urethral neoplasm 0 trials Sub-types →
- Urethral villous adenoma 0 trials
-
Prostate phyllodes tumor 0 trials
2 sub-types
- Benign prostate phyllodes tumor 0 trials
- Malignant prostate phyllodes tumor 0 trials
Most studied deeper sub-types
-
Experimental bladder cancer drug shows promise but trial halted early
Disease control Stopped earlyThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer drugs, in people with advanced bladder or urinary tract cancer. The goal was to see if the drug could shrink tumors and control the disease. The trial included 348 participants but was te…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control Stopped earlyThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Phase 2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC